Publication | Closed Access
Cysteine scavengers. 2. Synthetic .alpha.-methylenebutyrolactones as potential tumor inhibitors
55
Citations
0
References
1974
Year
Cysteine ScavengersChemoprevention StrategyAltmetric Attention ScorePathologyPharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal ChemistryAnti-cancer AgentCancer ResearchBiochemistryMedicineSocial Media PresenceCancer TreatmentDrug DevelopmentSynthetic .Alpha.-methylenebutyrolactonesPharmacologyNatural SciencesOncologyDrug Discovery
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTCysteine scavengers. 2. Synthetic .alpha.-methylenebutyrolactones as potential tumor inhibitorsAndre Rosowsky, Nickolas Papathanasopoulos, Herbert Lazarus, George E. Foley, and Edward J. ModestCite this: J. Med. Chem. 1974, 17, 7, 672–676Publication Date (Print):July 1, 1974Publication History Published online1 May 2002Published inissue 1 July 1974https://pubs.acs.org/doi/10.1021/jm00253a003https://doi.org/10.1021/jm00253a003research-articleACS PublicationsRequest reuse permissionsArticle Views140Altmetric-Citations49LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts